Schedule 13D ownership disclosure

NGM BIOPHARMACEUTICALS INC

Security class unavailable · CUSIP: 62921N105

Event date: 2023-12-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
13.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950142-23-003085
Form type
SC 13D/A
Filer
COLUMN GROUP L P
CIK
CIK 1347769
Filed
Dec 29, 2023
Reporting period
Dec 28, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub